Repository logo
Communities & Collections
All of UMU-IR
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Sahay, Rakesh"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
    (Indian Journal of Endocrinology and Metabolism, 2018) Kalra, Sanjay; Bahendeka, Silver; Sahay, Rakesh; Ghosh, Sujoy; Md, Fariduddin; Orab, Abbas; Ramaiya, Kaushik; Shammari, Sameer Al; Shrestha, Dina; Shaikh, Khalid; Abhayaratna, Sachitha; Shrestha K, Pradeep; Mahalingam, Aravinthan; Askheta, Mazen; Rahim, Aly Ahmed A; Eliana, Fatimah; Shrestha, Hari K.; Chaudhary, Sandeep; Ngugi, Nancy; Mbanya, Jean Claude; Aye, Than Than; Latt, Tint Swe; Akanov, Zhanay A.; Syed, Abbas Raza; Tandon, Nikhil; Unnikrishnan, A. G.; Madhu, S. V.; Jawa, Ali; Chowdhury, Subhankar; Bajaj, Sarita; Das, Ashok Kumar
    For decades, sulfonylureas(SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and weight gain with some SUs have led to discussion on their safety and utility. It has to be borne in mind that the adverse events associated with SUs should not be ascribed to the whole class, as many modern SUs, such as glimepiride and gliclazide modified release, are associated with better safety profiles. Furthermore, individualization of treatment, using SUs in combination with other drugs, backed with careful monitoring and patient education, ensures maximum benefits with minimal side effects. The current guidelines, developed by experts from Africa, Asia, and the Middle East, promote the safe and smart use of SUs in combination with other glucose‑lowering drugs.
  • Loading...
    Thumbnail Image
    Item
    Euthymia in Diabetes
    (Springer Nature, 2019-04-22) Kalra, Sanjay; Das, A.K; Baruah, M. P.; Unnikrishnan, A. G.; Dasgupta, Arundhati; Shah, Parag; Sahay, Rakesh; Shukla, Rishi; Das, Sambit; Tiwaskar, Mangesh; Vijayakumar, G.; Chawla, Manoj; Eliana, Fatimah; Suastika, Ketut; Orabi, Abbas; Abdul Rahim, Aly Ahmed; Uloko, Andrew; Lamptey, Roberta; Ngugi, Nancy; Bahendeka, Silver; Abdela, Abdurezak Ahmed; Mohammed, Fariduddin; Pathan, Mohammed Faruque; Rahman, Muhammed Hafizur; Afsana, Faria; Selim, Shajada; Moosa, Muaz; Murad, Moosa; Shreshtha, Pradeep Krishna; Shreshtha, Dina; Giri, Mimi; Hussain, Wiam; Al-Ani, Ahmed; Ramaiya, Kaushik; Singh, Surender; Raza, Syed Abbas; Aye, Than Than; Garusinghe, Chaminda; Muthukuda, Dimuthu; Weerakkody, Muditha; Kahandawa, Shyaminda; Bavuma, Charlotte; Ruder, Sundeep; Vanny, Koy; Khanolkar, Manish; Czupryniak, Leszek
    Aim: To develop an evidence-based expert group opinion on various types of euthymia associated with diabetes mellitus (DM) and its management. Background: Diabetes mellitus is a metabolic syndrome characterized by diverse biomedical and psychosocial features. Emotional health disturbances may lead to psychological and psychiatric dysfunction and may negatively influence glycemic control. Patients with DM may experience diabetes distress (DD) associated with burden of self-care, interpersonal issues, and emotional worries regarding the ability to cope with the illness. Euthymia or a state of positive mental health and psychological well-being should be considered a key outcome of diabetes care. Therefore, to achieve optimal outcomes, the consideration and measurement of psychological and psychiatric aspects along with glycemic levels are very important. A group of multidisciplinary clinical experts came together in an international meeting held in India to develop a workable concept for euthymia in diabetes care. A multidisciplinary approach was suggested to enhance the clinical outcomes and facilitate patient-centered care. During the meeting emphasis was given to the concept of a euthymia model in diabetes care. This model focuses on enhancement of self-care skills in diabetic patients and preventative health awareness among diabetes care providers. Euthymia also encompasses patient–provider communication to aid enhancement of coping skills. Results: After due discussions and extensive deliberations, the expert group provided several recommendations on implementing the concept of euthymia in DM care. Conclusions: Introduction of the concept of euthymia in routine clinical practice is important to improve the quality of life and coping skills in patients with DM. A timely clinical assessment of psychological and psychiatric aspects along with patient-reported outcomes of diabetes contributes to overall health and wellbeing of affected individuals.

Uganda Martyrs University copyright ©2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback